|
| |
Image Results
Loading...
Loading...
ImmunoGen Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Targeted Therapies for Cancer: ImmunoGen, Inc.
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood ...
http://www.immunogen.com/...
|
Antigen - Wikipedia, the free encyclopedia
Similarly, an immunogen is seen as a specific type of antigen. ... Cells present their immunogenic-antigens to the immune system via a histocompatibility ...
http://en.wikipedia.org/wiki/Antigen...
|
Job Opportunities: ImmunoGen, Inc.
ImmunoGen offers a rich and exciting work environment that gives its employees the power to succeed, the flexibility to grow intellectually and the ...
http://www.immunogen.com/wt/page/jobs...
|
ImmunoGen, Inc. - Google Finance
Get the latest on ImmunoGen, Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:IMGN...
|
Contact Us: ImmunoGen, Inc.
24 Mar 2008 ... ImmunoGen, Inc. 830 Winter Street Waltham, MA 02451-1477. Tel 781-895-0600 ... ImmunoGen, Inc. 333 Providence Highway Norwood, MA 02062 ...
http://www.immunogen.com/wt/page/contact...
|
Evaluation of HIV-1 immunogen, an immunologic modifier ...
Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized ...
http://www.ncbi.nlm.nih.gov/pubmed/11056590...
|
Product Pipeline: ImmunoGen, Inc.
16 Oct 2009 ... Wholly-owned by ImmunoGen sanofi-aventis. Biogen Idec Biotest ... *Centocor has opt-in rights **ImmunoGen has opt-in rights ...
http://www.immunogen.com/wt/page/pipeline...
|
News: Amgen to Apply ImmunoGen TAP Technology to Another Cancer ...
20 Nov 2009 ... Amgen licensed the exclusive right to use ImmunoGen's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer ...
http://www.genengnews.com/news/bnitem.aspx?name=69043975...
|
Corporate Officers: ImmunoGen, Inc.
22 Oct 2009 ... Daniel Junius joined ImmunoGen as Chief Financial Officer (CFO) and Senior Vice President, Finance in May 2005, was promoted to Executive ...
http://www.immunogen.com/wt/page/leadership...
|
The impact of a boosting immunogen on the differentiation of ...
In the present study we evaluated the effect of three different immunogens-- recombinant vaccinia, recombinant adenovirus, and plasmid DNA--on the generation ...
http://www.ncbi.nlm.nih.gov/pubmed/17881444...
|
|